Functional changes in Duchenne muscular dystrophy

Neurology

Volumn 77, Issue 3, 2011, Pages 250-256

  Mazzone, E ^a   Vasco, G ^a   Sormani, M P ^a,b,e   Torrente, Y ^c   Berardinelli, A ^d   Messina, S ^h   D'Amico, A ^f   Doglio, L ^g   Politano, L ^h   Cavallaro, F ^e   Frosini, S ⁱ   Bello, L ^k   Bonfiglio, S ^c   Zucchini, E ^l   De Sanctis, R ^a   Scutifero, M ^a   Bianco, F ^a   Rossi, F ^m   Motta, M C ^d   Sacco, A ^a   Donati, M A ^m   Mongini, T ^m   Pini, A ^l   Battini, R ^j   Pegoraro, E ^k   Pane, M ^a   Gasperini, S ^m   Previtali, S ⁿ   Napolitano S , ⁿ   Martinelli, D ^a,f   Bruno, C ^g,j   Vita, G ^e   Comi, G ^c   Bertini, E ^f   Mercuri, E ^a,o   more..

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF MESSINA   (Italy)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^g G GASLINI INSTITUTE   (Italy)

^h SECOND UNIVERSITY OF NAPLES   (Italy)

ⁱ DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

^j UNIVERSITY OF PADOVA   (Italy)

^k MAGGIORE HOSPITAL   (Italy)

^l UNIVERSITY OF TURIN   (Italy)

^m UNIVERSITY OF FLORENCE   (Italy)

ⁿ SAN RAFFAELE HOSPITAL   (Italy)

^o FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DEFLAZACORT; PREDNISOLONE;

6-MINUTE WALK TEST; ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DUCHENNE MUSCULAR DYSTROPHY; FUNCTIONAL STATUS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NORTH STAR AMBULATORY ASSESSMENT; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RATING SCALE; SCHOOL CHILD;

EID: 80051478879     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318225ab2e     Document Type: Article

References (15)

1. McDonald CM, Henricson EK, Han JJ, et al. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve 2010;41:500-510.
2. Kierkegaard M, Tollback A. Reliability and feasibility of the six minute walk test in subjects with myotonic dystrophy. Neuromuscul Disord 2007;17:94-99.
3. Wokke JH, Escolar DM, Pestronk A, et al. Clinical features of late-onset Pompe disease: A prospective cohort study. Muscle Nerve 2008;38:1236-1245.
4. Takeuchi Y, Katsuno M, Banno H, et al. Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Muscle Nerve 2008;38:964-971.
5. Novak P, Burger H, Marincek C, Meh D. Influence of foot pain on walking ability of diabetic patients. J Rehabil Med 2004;36:249-252. (Pubitemid 40124805)
6. Mazzone E, Martinelli D, Berardinelli A, et al. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul Disord 2010;20:712-716.
7. Mazzone ES, Messina S, Vasco G, et al. Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord 2009;19:458-461.
8. Scott E, Eagle M, Main M, Sheehan J. The North Star Ambulatory Assessment, Abstract 31st annual meeting of the British Paediatric Neurology Association: 18th-20th January 2006. Dev Med Child Neurol 2006;27.
9. Eagle M, Scott E, Main M, et al. Steroids in Duchenne muscular dystrophy (DMD): natural history and clinical evaluation using the North Star Ambulatory Assessment (NSAA): Abstract World Muscle Society, Taormina, Italy 17-20 October 2007. Neuromuscul Disord 2007;17:774.
10. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117.
11. Biggar WD, Harris VA, Eliasoph L, Alman B. Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscul Disord 2006;16:249-255.
12. Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010;9:77-93.
13. Sejerson T, Bushby K. Standards of care for Duchenne muscular dystrophy: brief TREAT-NMD recommendations. Adv Exp Med Biol 2009;652:13-21.
14. Biggar WD, Gingras M, Fehlings DL, et al. Deflazacort treatment of Duchenne muscular dystrophy. J Pediatr 2001;138:45-50. (Pubitemid 32097140)
15. Biggar WD, Politano L, Harris VA, et al. Deflazacort in Duchenne muscular dystrophy: A comparison of two different protocols. Neuromuscul Disord 2004;14:476-482. (Pubitemid 39141702)